Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 38

1.

Histopathology as a predictive biomarker: strengths and limitations.

Cardiff RD, Gregg JP, Miller JW, Axelrod DE, Borowsky AD.

J Nutr. 2006 Oct;136(10):2673S-5S. No abstract available.

2.

Protein arrays for biomarker discovery.

Reid JD, Parker CE, Borchers CH.

Curr Opin Mol Ther. 2007 Jun;9(3):216-21. Review.

PMID:
17608019
3.

Prognostic versus predictive value of biomarkers in oncology.

Oldenhuis CN, Oosting SF, Gietema JA, de Vries EG.

Eur J Cancer. 2008 May;44(7):946-53. doi: 10.1016/j.ejca.2008.03.006. Epub 2008 Apr 7. Review.

PMID:
18396036
4.

Proteomics-driven cancer biomarker discovery: looking to the future.

Simpson RJ, Bernhard OK, Greening DW, Moritz RL.

Curr Opin Chem Biol. 2008 Feb;12(1):72-7. doi: 10.1016/j.cbpa.2008.02.010. Epub 2008 Mar 11. Review.

PMID:
18295612
5.

Serum biomarker profiling in cancer studies: a question of standardisation?

Matharoo-Ball B, Miles AK, Creaser CS, Ball G, Rees R.

Vet Comp Oncol. 2008 Dec;6(4):224-47. doi: 10.1111/j.1476-5829.2008.00171.x. Review.

PMID:
19178682
6.

Cancer stem cells: implications for cancer treatment and prevention.

Kakarala M, Wicha MS.

Cancer J. 2007 Sep-Oct;13(5):271-5. Review. No abstract available.

PMID:
17921723
7.

Implication of aberrant glycosylation in cancer and use of lectin for cancer biomarker discovery.

Kim YS, Yoo HS, Ko JH.

Protein Pept Lett. 2009;16(5):499-507. Review.

PMID:
19442229
8.

Biomarkers for diet and cancer prevention research: potentials and challenges.

Davis CD, Milner JA.

Acta Pharmacol Sin. 2007 Sep;28(9):1262-73. Review.

9.

The role of electrophoresis in disease biomarker discovery.

Issaq HJ, Veenstra TD.

Electrophoresis. 2007 Jun;28(12):1980-8. Review.

PMID:
17503404
10.

Antioxidant vitamins and cancer risk: is oxidative damage to DNA a relevant biomarker?

Loft S, Møller P, Cooke MS, Rozalski R, Olinski R.

Eur J Nutr. 2008 May;47 Suppl 2:19-28. doi: 10.1007/s00394-008-2004-0. Review.

PMID:
18458832
11.

Molecular determinants of outcomes: linking tissue banks to outcomes databases.

Bathe OF.

J Surg Oncol. 2009 Jun 15;99(8):513-6. doi: 10.1002/jso.21152. Review.

PMID:
19466742
12.

Old disease, new culprit: tumor stem cells in cancer.

Lee JT, Herlyn M.

J Cell Physiol. 2007 Dec;213(3):603-9. Review.

PMID:
17786956
13.
14.

Oncopeptidomics--a commentary on opportunities and limitations.

Tammen H, Zucht HD, Budde P.

Cancer Lett. 2007 Apr 28;249(1):80-6. Epub 2007 Jan 31. Review.

PMID:
17275178
15.

Molecular markers and targets for colorectal cancer prevention.

Janakiram NB, Rao CV.

Acta Pharmacol Sin. 2008 Jan;29(1):1-20. Review.

16.

Survivin: a promising tumor biomarker.

Duffy MJ, O'Donovan N, Brennan DJ, Gallagher WM, Ryan BM.

Cancer Lett. 2007 Apr 28;249(1):49-60. Epub 2007 Feb 1. Review.

PMID:
17275177
17.

Proliferation markers for the differential diagnosis of tumor and inflammation.

van Waarde A, Elsinga PH.

Curr Pharm Des. 2008;14(31):3326-339. Review.

PMID:
19075707
18.

Comparisons of metastases in different organs: biological and clinical implications.

Tarin D.

Clin Cancer Res. 2008 Apr 1;14(7):1923-5. doi: 10.1158/1078-0432.CCR-07-5259. Review. No abstract available.

19.

Beta2-microglobulin: emerging as a promising cancer therapeutic target.

Shi C, Zhu Y, Su Y, Chung LW, Cheng T.

Drug Discov Today. 2009 Jan;14(1-2):25-30. doi: 10.1016/j.drudis.2008.11.001. Epub 2008 Dec 26. Review.

PMID:
19056512
20.

Dynamics of tumor hypoxia measured with bioreductive hypoxic cell markers.

Ljungkvist AS, Bussink J, Kaanders JH, van der Kogel AJ.

Radiat Res. 2007 Feb;167(2):127-45. Review.

PMID:
17390721
Items per page

Supplemental Content

Write to the Help Desk